Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada.
Front Immunol. 2022 Jun 10;13:874308. doi: 10.3389/fimmu.2022.874308. eCollection 2022.
Infection with helminths or parasitic worms are highly prevalent worldwide especially in developing regions. Helminths cause chronic infections that are associated with suppression of immune responses to unrelated pathogens, vaccines, and by-stander antigens responsible for dysregulated immune responses as occurs in diseases such as allergies. Helminths use multiple mechanisms to modulate the immune system to evade the highly polarized type 2 immune response required to expel adult worms and for immunity to reinfection. Anthelmintic drugs are efficient in reducing adult worm burdens in helminth-infected individuals, but resistance to these drugs is rapidly increasing and vaccines against these pathogens are not available. Emerging evidence indicate that helminths induce myeloid-derived suppressor cells (MDSC), originally described in tumor-bearing mice and cancer patients. MDSC are a heterogenous population of immature cells that consist of two distinct sub-populations, polymorphonuclear (PMN)-MDSC and monocytic (M)-MDSC based on morphology and phenotype. MDSC suppress the function of T cells and other innate and adaptive immune cells including NK cells and B cells. During cancer or infection with bacteria or viruses, there is marked expansion of MDSC. Furthermore, the frequencies of MDSC correlate inversely with the prognosis and survival of tumor-bearing hosts as well as bacterial and viral burdens, persistence, and outcome in infected hosts. Currently, there is a paucity of data on MDSC and helminth infections. Here, we provide a survey of the evidence accumulated so far that overall support a role for MDSC in modulating immune responses during helminth infections. We review data from studies in various helminths, including those that infect humans. Finally, we summarize the progress to date in understanding the role of MDSC in helminth infections and briefly discuss potential host-directed strategies to target MDSC-mediated suppression of immune responses to helminths in favor of development of immunity to eliminate adult worms and possibly induce protection against reinfection.
寄生虫感染在全球范围内非常普遍,尤其是在发展中国家。寄生虫会引起慢性感染,从而抑制对无关病原体、疫苗和旁观者抗原的免疫反应,导致免疫失调,如过敏等疾病。寄生虫利用多种机制来调节免疫系统,以逃避清除成虫所需的高度极化的 2 型免疫反应,并产生对再感染的免疫力。驱虫药物在减少寄生虫感染个体的成虫负担方面非常有效,但这些药物的耐药性正在迅速增加,而且这些病原体还没有疫苗。新出现的证据表明,寄生虫会诱导髓源抑制细胞(MDSC),最初在肿瘤荷瘤小鼠和癌症患者中描述。MDSC 是一种异质性不成熟细胞群体,根据形态和表型可分为两种不同的亚群,即多形核(PMN)-MDSC 和单核(M)-MDSC。MDSC 抑制 T 细胞和其他先天和适应性免疫细胞的功能,包括 NK 细胞和 B 细胞。在癌症或细菌或病毒感染期间,MDSC 会显著扩增。此外,MDSC 的频率与肿瘤荷瘤宿主的预后和存活率以及细菌和病毒负荷、持续时间和感染宿主的结果呈负相关。目前,关于 MDSC 和寄生虫感染的数据很少。在这里,我们提供了迄今为止积累的证据综述,这些证据总体上支持 MDSC 在调节寄生虫感染期间的免疫反应中发挥作用。我们回顾了来自各种寄生虫感染研究的数据,包括感染人类的寄生虫。最后,我们总结了迄今为止对 MDSC 在寄生虫感染中的作用的理解进展,并简要讨论了潜在的宿主导向策略,以靶向 MDSC 介导的对寄生虫的免疫抑制,有利于发展消除成虫和可能诱导对再感染的保护的免疫力。